Aytu Biopharma (AYTU) Other Non-Current Assets (2013 - 2026)
Aytu Biopharma (AYTU) reported Other Non-Current Assets of $556000.0 for Q1 2026, down 24.66% quarter-over-quarter from $738000.0 in Q4 2025.
Aytu Biopharma (AYTU) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 14 years of Other Non-Current Assets data on file, last reported at $556000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $556000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $556000.0 (changed N/A YoY), and the FY2025 annual result was $1.2 million, up 2636.36% from the prior year.
- Other Non-Current Assets fell to $556000.0 in Q1 2026 per AYTU's latest filing, from $738000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $2.5 million in Q2 2023 and troughed at $44000.0 in Q2 2024.
- A 5-year average of $905428.6 and a median of $825000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slumped 98.27% in 2024, then jumped 2636.36% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $821000.0 in 2022, then gained by 10.48% to $907000.0 in 2023, then tumbled by 95.15% to $44000.0 in 2024, then soared by 1577.27% to $738000.0 in 2025, then slipped by 24.66% to $556000.0 in 2026.
- Business Quant data shows AYTU's Other Non-Current Assets at $556000.0 in Q1 2026, $738000.0 in Q4 2025, and $939000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | 556,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 556,000.00 |
| Dec 31, 2025 | 738,000.00 |
| Sep 30, 2025 | 939,000.00 |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 889,000.00 |
| Dec 31, 2023 | 907,000.00 |
| Sep 30, 2023 | 772,000.00 |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 892,000.00 |
| Dec 31, 2022 | 821,000.00 |
| Sep 30, 2022 | 829,000.00 |
| Jun 30, 2022 | 766,000.00 |
| Mar 31, 2022 | 774,000.00 |
| Dec 31, 2021 | 457,000.00 |
| Sep 30, 2021 | 465,000.00 |
| Jun 30, 2021 | 465,000.00 |
| Dec 31, 2020 | 16,023.00 |
| Sep 30, 2020 | 16.02 Mn |
| Jun 30, 2020 | 33,000.00 |